Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Gowen

Showing results (101-110 of 118) with videos related to

Pageof 12
Sort By:
The Journal of Clinical Investigation|June 7, 2000
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic ratsM Gowen, G B Stroup, R A Dodds, et al.
Journal of Cellular Biochemistry|February 2, 2000
Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human boneW P Prichett, A J Patton, J A Field, et al.
Osteoarthritis and Cartilage|November 9, 2000
FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosisI E James, S Kumar, M R Barnes, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivoB J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized ratM W Lark, G B Stroup, R A Dodds, et al.
The Journal of Biological Chemistry|June 8, 1999
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functionsS Kumar, A T Hand, J R Connor, et al.
Bone|May 9, 2002
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized ratMichael W Lark, G B Stroup, I E James, et al.
Pageof 12

Showing results (101-110 of 118) with videos related to

Sort By:
Pageof 12
The Journal of Clinical Investigation|June 7, 2000
Antagonizing the parathyroid calcium receptor stimulates parathyroid hormone secretion and bone formation in osteopenic ratsM Gowen, G B Stroup, R A Dodds, et al.
Journal of Cellular Biochemistry|February 2, 2000
Identification and cloning of a human urea transporter HUT11, which is downregulated during adipogenesis of explant cultures of human boneW P Prichett, A J Patton, J A Field, et al.
Osteoarthritis and Cartilage|November 9, 2000
FrzB-2: a human secreted frizzled-related protein with a potential role in chondrocyte apoptosisI E James, S Kumar, M R Barnes, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|September 1, 1997
Peptide aldehyde inhibitors of cathepsin K inhibit bone resorption both in vitro and in vivoB J Votta, M A Levy, A Badger, et al.
The Journal of Biological Chemistry|January 20, 2001
Potent and selective cathepsin L inhibitors do not inhibit human osteoclast resorption in vitroI E James, R W Marquis, S M Blake, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|October 5, 2001
Potent and selective inhibition of human cathepsin K leads to inhibition of bone resorption in vivo in a nonhuman primateG B Stroup, M W Lark, D F Veber, et al.
Bone|September 12, 2006
A highly potent inhibitor of cathepsin K (relacatib) reduces biomarkers of bone resorption both in vitro and in an acute model of elevated bone turnover in vivo in monkeysS Kumar, L Dare, J A Vasko-Moser, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|February 24, 2001
Antagonism of the osteoclast vitronectin receptor with an orally active nonpeptide inhibitor prevents cancellous bone loss in the ovariectomized ratM W Lark, G B Stroup, R A Dodds, et al.
The Journal of Biological Chemistry|June 8, 1999
Identification and cloning of a connective tissue growth factor-like cDNA from human osteoblasts encoding a novel regulator of osteoblast functionsS Kumar, A T Hand, J R Connor, et al.
Bone|May 9, 2002
A potent small molecule, nonpeptide inhibitor of cathepsin K (SB 331750) prevents bone matrix resorption in the ovariectomized ratMichael W Lark, G B Stroup, I E James, et al.
Pageof 12